Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial

Author:

Baisley Kathy12ORCID,Orne‐Gliemann Joanna3,Larmarange Joseph4ORCID,Plazy Melanie3,Collier Dami56,Dreyer Jaco1,Mngomezulu Thobeka1,Herbst Kobus17,Hanekom Willem15,Dabis Francois3,Siedner Mark J.18ORCID,Iwuji Collins19ORCID

Affiliation:

1. Africa Health Research Institute Durban South Africa

2. Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine London UK

3. University of Bordeaux Inserm Institut de Recherche pour le Développement (IRD) UMR 1219 Bordeaux France

4. Centre Population et Développement (Ceped) Institut de Recherche pour le Développement (IRD) Université de Paris Inserm Paris France

5. Division of Infection and Immunity University College London London UK

6. Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) Cambridge UK

7. DSI‐MRC South African Population Research Infrastructure Network Durban South Africa

8. Harvard Medical School Boston Massachusetts USA

9. Department of Global Health and Infection Brighton and Sussex Medical School University of Sussex Brighton UK

Funder

Agence Nationale de Recherches sur le Sida et les Hépatites Virales

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference19 articles.

1. UNAIDS.UNAIDS Data 2020.https://www.unaids.org/sites/default/files/media_asset/2020_aids‐data‐book_en.pdf. Accessed September 20 2020.

2. STATS SA.Mid‐year population estimates 2018.http://www.statssa.gov.za/publications/P0302/P03022018.pdf. Accessed September 20 2020.

3. Prevention of HIV-1 Infection with Early Antiretroviral Therapy

4. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

5. WHO.Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Recommendations for a public health approach 2016. Second:https://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf;jsessionid=189F0596C29A19BFF9510F0CF471847C?sequence=1. Accessed May 18 2020.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3